Depreciation in USD of BioCardia, Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BioCardia, Inc. quarterly/annual Depreciation history and change rate from 2015 to Q3 2025.
  • BioCardia, Inc. Depreciation for the quarter ending 30 Sep 2025 was $4,000.000, a 75% decline year-over-year.
  • BioCardia, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $36,000.000, a 50% decline year-over-year.
  • BioCardia, Inc. annual Depreciation for 2024 was $67,000.000, a 20.2% decline from 2023.
  • BioCardia, Inc. annual Depreciation for 2023 was $84,000.000, a 2.44% increase from 2022.
  • BioCardia, Inc. annual Depreciation for 2022 was $82,000.000, a 36.7% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BioCardia, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $36,000 $4,000 -$12,000 -75% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $48,000 $5,000 -$12,000 -70.6% 01 Apr 2025 30 Jun 2025 10-Q/A 29 Oct 2025
Q1 2025 $60,000 $12,000 -$7,000 -36.8% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $67,000 $15,000 -$5,000 -25% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 $72,000 $16,000 -$5,000 -23.8% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $77,000 $17,000 -$4,000 -19% 01 Apr 2024 30 Jun 2024 10-Q/A 29 Oct 2025
Q1 2024 $81,000 $19,000 -$3,000 -13.6% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $84,000 $20,000 +$4,000 +25% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $80,000 $21,000 -$8,000 -27.6% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $88,000 $21,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $88,000 $22,000 +$6,000 +37.5% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $82,000 $16,000 +$1,000 +6.7% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024
Q3 2022 $81,000 $29,000 +$14,000 +93.3% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $67,000 $21,000 +$5,000 +31.2% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $62,000 $16,000 +$2,000 +14.3% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2022
Q4 2021 $60,000 $15,000 +$6,000 +66.7% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $54,000 $15,000 $0 0% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $54,000 $16,000 -$6,000 -27.3% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $60,000 $14,000 -$8,000 -36.4% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $68,000 $9,000 -$24,000 -72.7% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 $92,000 $15,000 -$14,000 -48.3% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $106,000 $22,000 -$4,000 -15.4% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $110,000 $22,000 -$1,000 -4.3% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $111,000 $33,000 +$11,000 +50% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 $100,000 $29,000 +$7,000 +31.8% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $93,000 $26,000 +$4,000 +18.2% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $89,000 $23,000 +$1,000 +4.5% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $88,000 $22,000 +$1,000 +4.8% 01 Oct 2018 31 Dec 2018 10-K 09 Apr 2020
Q3 2018 $87,000 $22,000 +$1,000 +4.8% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019
Q2 2018 $86,000 $22,000 -$1,000 -4.3% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $87,000 $22,000 +$9,000 +69.2% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $78,000 $21,000 +$12,000 +1.3% 01 Oct 2017 31 Dec 2017 10-K 09 Apr 2020
Q3 2017 $66,000 $21,000 +$12,000 +1.3% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $54,000 $23,000 +$12,000 +1.1% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 $42,000 $13,000 +$3,000 +30% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 $39,000 $9,000 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2019
Q3 2016 $9,000 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $11,000 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 $10,000 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017

BioCardia, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $67,000 -$17,000 -20.2% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 $84,000 +$2,000 +2.4% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 $82,000 +$22,000 +36.7% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024
2021 $60,000 -$8,000 -11.8% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023
2020 $68,000 -$43,000 -38.7% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 $111,000 +$23,000 +26.1% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 $88,000 +$10,000 +12.8% 01 Jan 2018 31 Dec 2018 10-K 09 Apr 2020
2017 $78,000 +$39,000 +100% 01 Jan 2017 31 Dec 2017 10-K 09 Apr 2020
2016 $39,000 -$8,000 -17% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2019
2015 $47,000 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.